Carregant...

Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure

OBJECTIVES: Telavancin is approved in Europe for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus when other alternatives are not suitable. The approved European prescribing information contraindicates the use of telavancin in patients with severe renal imp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Torres, A., Rubinstein, E., Corey, G. R., Stryjewski, M. E., Barriere, S. L.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023300/
https://ncbi.nlm.nih.gov/pubmed/24398339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkt490
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!